Evidence map›Paper›PMID 42638892›Full record

ArticleSmart molecules : open access2026

Bo Zhang, Chuang Du, Yuewen Yang, Dongping Xu, Xin-Dong Jiang, Hui-Xin Liu, Gaowu Qin

Abstract read
In one paragraph

Article in Smart molecules : open access, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Bo ZhangInstitute for Strategic Materials and Components Shenyang University of Chemical Technology Shenyang China.
Chuang DuInstitute of Life Sciences China Medical University Shenyang China.
Yuewen YangInstitute for Strategic Materials and Components Shenyang University of Chemical Technology Shenyang China.ORCID https://orcid.org/0000-0003-0914-5276
Dongping XuInstitute for Strategic Materials and Components Shenyang University of Chemical Technology Shenyang China.
Xin-Dong JiangInstitute for Strategic Materials and Components Shenyang University of Chemical Technology Shenyang China.ORCID https://orcid.org/0000-0002-9780-1124
Hui-Xin LiuInstitute of Life Sciences China Medical University Shenyang China.ORCID https://orcid.org/0000-0002-8981-9981
Gaowu QinInstitute for Strategic Materials and Components Shenyang University of Chemical Technology Shenyang China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Development of boron-dipyrromethene (BODIPY)-based phototherapeutic agents integrating photodynamic and photothermal therapy is limited by restricted modifiable sites on traditional scaffolds. Herein, we report a quinoline-fused cyclic pyrrole Npy generated by an lithium diisopropylamide-catalyzed [3 + 2] cyclization, which incorporates a nitrogen atom into a rigid polycyclic π-system. Using this pyrrole Npy, a symmetric photosensitizer Npy-BDP with absorption at 660 nm was prepared with a singlet oxygen quantum yield of 0.38, and efficient type-I reactive oxygen species generation. Upon nanoparticle encapsulation, Npy-BDP forms

Indexed as

BODIPYHj‐aggregatequinoline‐fused pyrroleROS

Identifiers

PMID42638892
PMCPMC13501090

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.